Showing results (31-40 of 702) with videos related to
Sort By:
Pageof 71
European Archives of Psychiatry and Clinical Neuroscience|August 23, 2002
Intravenous antidepressant treatment: focus on citalopramS Kasper, F Müller-SpahnExpert Opinion on Pharmacotherapy|March 16, 2001
Review of quetiapine and its clinical applications in schizophreniaS Kasper, F Müller-SpahnEuropean Neurology|November 24, 1999
ELISA-quantitation of phosphorylated tau protein in the Alzheimer's disease brainM Herrmann, S Golombowski, K Kräuchi, et al.Fortschritte Der Neurologie-Psychiatrie|September 1, 1991
[Clinical effectiveness of zotepine in treatment of negative schizophrenic symptoms. Results of an open and a double-blind controlled trial]F Müller-Spahn, D Dieterle, M AckenheilDer Nervenarzt|July 1, 1992
[New aspects in the diagnosis, pathogenesis and therapy of schizophrenic negative symptoms]F Müller-Spahn, S Modell, M ThommaDer Nervenarzt|May 1, 1993
[Paranoid psychosis in a patient with hypothyroidism and vitamin B12 deficiency]S Modell, D Naber, F Müller-SpahnFortschritte Der Neurologie-Psychiatrie|November 1, 1993
[Atypical neuroleptics, pharmacology and clinical importance]U Klages, H Hippius, F Müller-SpahnEuropean Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Psychodrug-induced and EDTA associated thrombocytopenia: important factors in the differential diagnosis of low platelet countsH Hampel, C Berger, F Müller-SpahnActa Haematologica|January 1, 1996
Modified oral anticoagulant potency in an amitriptyline-treated patient?H Hampel, C Berger, F Müller-SpahnJournal of Neural Transmission (Vienna, Austria : 1996)|May 20, 1998
Increased blood mercury levels in patients with Alzheimer's diseaseC Hock, G Drasch, S Golombowski, et al.Pageof 71